91³Ô¹ÏÍø

Contact

Click here for a confidential contact or call:

1-347-417-2192

The Antitrust Week in Review

Posted  February 2, 2015

Here are some of the developments in antitrust news this past week that we found interesting and are following.

.  Federal courts often find the extent to which U.S. antitrust laws have a global reach to be one of the thorniest issues to deal with.  The U.S. Court of Appeals for the Second Circuit is wrestling with this issue as it reviews a $147.8 million jury verdict against two Chinese vitamin C makers.

.   Two top supermarket chains are having a special sale – 168 stores – in order to win FTC approval of their $9.2 billion merger.

.  Pharmaceutical companies Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd. have agreed to divest Ranbaxy’s interests in generic minocycline tablets  in order to settle FTC charges that Sun’s $4 billion proposed acquisition of Ranbaxy would be anticompetitive.  Completion of the deal would create the world’s fifth-largest  (and India’s largest) drug maker.

Tagged in: Antitrust Litigation,